Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience
dc.contributor.author | Voulgari, P. V. | en |
dc.contributor.author | Venetsanopoulou, A. I. | en |
dc.contributor.author | Epagelis, E. K. | en |
dc.contributor.author | Alamanos, Y. | en |
dc.contributor.author | Takalou, I. | en |
dc.contributor.author | Drosos, A. A. | en |
dc.date.accessioned | 2015-11-24T19:10:07Z | |
dc.date.available | 2015-11-24T19:10:07Z | |
dc.identifier.issn | 0003-4967 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20792 | |
dc.rights | Default Licence | - |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Antibodies, Monoclonal/*therapeutic use | en |
dc.subject | Arthritis, Psoriatic/*drug therapy/pathology | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Immunosuppressive Agents/*therapeutic use | en |
dc.subject | Joints/pathology | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Psoriasis/drug therapy | en |
dc.subject | Skin/pathology | en |
dc.subject | Tumor Necrosis Factor-alpha/*antagonists & inhibitors | en |
dc.title | Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1136/ard.2006.058735 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/17068063 | - |
heal.identifier.secondary | http://ard.bmj.com/content/66/2/270 | - |
heal.journalName | Ann Rheum Dis | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2007 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: